For an A‑negative patient undergoing liver transplantation whose donor is O‑positive, which blood type should be transfused?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Blood Transfusion for A-Negative Patient with O-Positive Liver Donor

For an A-negative patient undergoing liver transplantation from an O-positive donor, transfuse O-negative red blood cells initially, then transition to A-negative red blood cells once available, while monitoring closely for passenger lymphocyte syndrome (PLS) and hemolysis starting around day 6 post-transplant.

Rationale for Blood Type Selection

Immediate Perioperative Period

In emergency or massive hemorrhage situations during liver transplantation, group O RhD negative red blood cells are the blood group of choice when immediate transfusion is needed 1. For women of childbearing potential (which includes your A-negative patient if <50 years old), O RhD negative blood should be prioritized to prevent RhD alloimmunization 2.

However, the guidelines acknowledge that O RhD positive blood is acceptable for males and postmenopausal females when O negative supplies are limited 3, 1. Given the scarcity of O-negative blood as a resource 3, once the patient's blood type is confirmed (approximately 10 minutes), group-specific blood (A-negative in this case) should be used at the earliest possible opportunity 1.

Post-Transplant Period: The Critical Complication

The major concern in this ABO-unmatched transplant scenario (O donor → A recipient) is passenger lymphocyte syndrome (PLS), which causes hemolytic anemia. This occurs when donor lymphocytes in the transplanted liver produce antibodies against the recipient's red blood cells.

Key clinical features of PLS:

  • Hemolysis typically begins 6-12 days post-transplant (mean 9.2 days) 4, 5
  • Hemoglobin can drop dramatically (mean decrease 4.8 g/dL) 4
  • Most problematic in O donor → A recipient transplants, with 56% developing donor-derived antibodies and hemolysis 4
  • Anti-A antibodies appear in patient serum and on red blood cell membranes 6, 5

Specific Transfusion Protocol

During Surgery and Immediate Post-Op

  • Use O-negative red blood cells if patient is female of childbearing age
  • Transition to A-negative red blood cells once blood bank confirms type (within 15-20 minutes) 2
  • Use plasma-poor red cells in optimal additive solution (leucodepleted) 3

Days 6-30 Post-Transplant (PLS Risk Period)

Monitor closely:

  • Daily hemoglobin and bilirubin levels starting day 6 5
  • Direct antiglobulin test (DAT) 5
  • Unexpected antibody screening 5

If hemolysis develops:

  • Transfuse O-negative washed red blood cells (not A-negative) 6, 4, 5
  • The "washed" component removes plasma antibodies
  • Continue O-negative transfusions until donor-derived antibodies clear (mean duration 15.2 days) 4
  • Consider corticosteroids (e.g., prednisolone 60 mg for 3 days) 6
  • Patients typically require 7-8 units during hemolytic period 4

After PLS Resolution

  • Resume A-negative red blood cells once DAT becomes negative and anti-A antibodies are no longer detectable

Critical Pitfalls to Avoid

  1. Do NOT transfuse A-negative blood during active PLS - the donor-derived anti-A antibodies will destroy the patient's own A-positive red cells 6, 4, 5

  2. Do NOT assume hemolysis won't occur - 56% of O→A liver transplants develop clinically significant hemolysis 4

  3. Do NOT wait for symptoms - begin monitoring hemoglobin and DAT on day 6 proactively 5

  4. Do NOT overlook the Rh status - while the donor is O-positive, this primarily affects platelet transfusions; for red cells, maintain A-negative or O-negative to prevent RhD alloimmunization if patient is female and childbearing age 1, 7

Platelet and Plasma Considerations

  • Platelets: Can use O-positive platelets, though they contain small amounts of RBCs (0.00043-0.036 mL) 7
  • Fresh frozen plasma: Use AB plasma (universal donor for plasma) or A plasma to avoid anti-A antibodies in O plasma that could cause hemolysis 7

This approach balances the immediate surgical needs with the predictable complication of PLS in ABO-mismatched liver transplantation, prioritizing patient safety while conserving scarce O-negative blood resources 3, 1.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.